Results 241 to 250 of about 5,875,188 (336)
Leveraging Statistical Process Control for continuous improvement of the manufacturing process
, 2015 Stephen Patrick Fuller
openalex +1 more source
Innovative Business Development. Statistical Control of Processes in Six Sigma
, 2018 Denis Anatol’Evich Zhevnov
openalex +2 more sources
Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin
Molecular Oncology, EarlyView.Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon +4 more
wiley +1 more source
Evaluation of Elekta Agility multi-leaf collimator performance using statistical process control tools. [PDF]
J Appl Clin Med Phys, 2019 Meyers SM, Balderson MJ, Létourneau D.
europepmc +1 more source
FEBS Open Bio, EarlyView.Representation of the suggested mode of action of lactoferrin (Lf) in nonsmall cell lung cancer (NSCLC) A549 cells. Lf induces activation of caspase‐3 by activating p53 and AChE leading to decreased ACh concentrations. In turn, ACh signaling leads to activation of VEGF and AKT and blocking of caspase‐3.
Stuti Goel +9 more
wiley +1 more source
Assessment of an elecrolytic galvanizing process through statistic modeling and control charts
, 2015 Flávio Roberto Andara
openalex +1 more source
Statistical process control in pulsed drip irrigation systems
Vinicius Cossich +4 more
openalex +2 more sources
Integrating SERVQUAL and Statistical Process Control Techniques for Service Quality Improvements in a University's Registrar Office [PDF]
John C. Chavez -
openalex +1 more source
FEBS Open Bio, EarlyView.CAF‐mediated immunosuppression in ovarian cancer is driven by IDO1, reducing T‐cell function. Inhibiting IDO1 restores T‐cell proliferation and cytotoxicity, increases cancer cell apoptosis, and may help overcome CAF‐induced immune suppression in high‐grade serous ovarian cancer. Targeting IDO1 may improve antitumor immunity.
Hyewon Lee +3 more
wiley +1 more source